LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $204,187 | -20.1% | 2,832 | -18.4% | 0.00% | 0.0% |
| Q1 2023 | $255,400 | +5.7% | 3,472 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $241,682 | -25.6% | 3,618 | -4.2% | 0.00% | 0.0% |
| Q3 2022 | $325,000 | +2.5% | 3,777 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $317,000 | -23.8% | 3,548 | -4.0% | 0.00% | 0.0% |
| Q1 2022 | $416,000 | -46.0% | 3,696 | -25.8% | 0.00% | -50.0% |
| Q4 2021 | $770,000 | +3.5% | 4,982 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $744,000 | +5.5% | 5,341 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $705,000 | -15.7% | 5,377 | -1.9% | 0.00% | -33.3% |
| Q1 2021 | $836,000 | +28.2% | 5,481 | -16.4% | 0.00% | +50.0% |
| Q4 2020 | $652,000 | -0.5% | 6,558 | -4.6% | 0.00% | -33.3% |
| Q3 2020 | $655,000 | -17.8% | 6,875 | -3.5% | 0.00% | -25.0% |
| Q2 2020 | $797,000 | +55.4% | 7,122 | +1.0% | 0.00% | +33.3% |
| Q1 2020 | $513,000 | -11.7% | 7,051 | +26.5% | 0.00% | 0.0% |
| Q4 2019 | $581,000 | +3.2% | 5,574 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $563,000 | +37.7% | 5,656 | +57.7% | 0.00% | +50.0% |
| Q2 2019 | $409,000 | -10.5% | 3,587 | -1.4% | 0.00% | 0.0% |
| Q1 2019 | $457,000 | +4.6% | 3,637 | +13.0% | 0.00% | -33.3% |
| Q4 2018 | $437,000 | -50.3% | 3,218 | +0.4% | 0.00% | -25.0% |
| Q3 2018 | $879,000 | -30.0% | 3,204 | -47.2% | 0.00% | -42.9% |
| Q2 2018 | $1,256,000 | +30.4% | 6,068 | +4.0% | 0.01% | 0.0% |
| Q1 2018 | $963,000 | +22.2% | 5,833 | +1.3% | 0.01% | +40.0% |
| Q4 2017 | $788,000 | -0.1% | 5,756 | -0.6% | 0.01% | -16.7% |
| Q3 2017 | $789,000 | +22.1% | 5,793 | +8.9% | 0.01% | +20.0% |
| Q2 2017 | $646,000 | +22.6% | 5,322 | +6.8% | 0.01% | +25.0% |
| Q1 2017 | $527,000 | +133.2% | 4,981 | +162.6% | 0.00% | +100.0% |
| Q2 2016 | $226,000 | -44.1% | 1,897 | -49.8% | 0.00% | -50.0% |
| Q1 2016 | $404,000 | +73.4% | 3,776 | +76.0% | 0.00% | +100.0% |
| Q4 2015 | $233,000 | -4.1% | 2,146 | -10.6% | 0.00% | -33.3% |
| Q2 2015 | $243,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |